|
1
|
Perri F, Della Vittoria Scarpati G,
Caponigro F, Ionna F, Longo F, Buonopane S, Muto P, Di Marzo M,
Pisconti S and Solla R: Management of recurrent nasopharyngeal
carcinoma: Current perspectives. Onco Targets Ther. 12:1583–1591.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
He Y, Guo T, Guan H, Wang J, Sun Y and
Peng X: Concurrent chemoradiotherapy versus radiotherapy alone for
locoregionally advanced nasopharyngeal carcinoma in the era of
intensity-modulated radiotherapy: A meta-analysis. Cancer Manag
Res. 10:1419–1428. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Wang L, Guo Y, Xu J, Chen Z, Jiang X,
Zhang L, Huang S, He X and Zhang Y: Clinical analysis of recurrence
patterns in patients with nasopharyngeal carcinoma treated with
intensity-modulated radiotherapy. Ann Otol Rhinol Laryngol.
126:789–797. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Cheng JZ, Chen JJ, Xue K, Wang ZG and Yu
D: Clinicopathologic and prognostic significance of VEGF, JAK2 and
STAT3 in patients with nasopharyngeal carcinoma. Cancer Cell Int.
18:1102018. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Liu J, Tang G, Huang H, Li H, Zhang P and
Xu L: Expression level of NUAK1 in human nasopharyngeal carcinoma
and its prognostic significance. Eur Arch Otorhinolaryngol.
275:2563–2573. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Tang J, Zhong G, Wu J, Chen H and Jia Y:
SOX2 recruits KLF4 to regulate nasopharyngeal carcinoma
proliferation via PI3K/AKT signaling. Oncogenesis. 7:612018.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Dragomir M, Mafra ACP, Dias SMG, Vasilescu
C and Calin GA: Using microRNA networks to understand cancer. Int J
Mol Sci. 19:E18712018. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Cheng JZ, Chen JJ, Wang ZG and Yu D:
MicroRNA-185 inhibits cell proliferation while promoting apoptosis
and autophagy through negative regulation of TGF-β1/mTOR axis and
HOXC6 in nasopharyngeal carcinoma. Cancer Biomark. 23:107–123.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhao X and Chu J: MicroRNA-379 suppresses
cell proliferation, migration and invasion in nasopharyngeal
carcinoma by targeting tumor protein D52. Exp Ther Med.
16:1232–1240. 2018.PubMed/NCBI
|
|
10
|
Yu JW, Mai W, Cui YL and Kong LY: Genes
and pathways identified in thyroid carcinoma based on
bioinformatics analysis. Neoplasma. 63:559–568. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Tokar T, Pastrello C, Rossos AEM, Abovsky
M, Hauschild AC, Tsay M, Lu R and Jurisica I: mirDIP
4.1-integrative database of human microRNA target predictions.
Nucleic Acids Res. 46:D360–D370. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Al-Mubaid H: Gene multifunctionality
scoring using gene ontology. J Bioinform Comput Biol.
16:18400182018. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kanehisa M, Furumichi M, Tanabe M, Sato Y
and Morishima K: KEGG: New perspectives on genomes, pathways,
diseases and drugs. Nucleic Acids Res. 45:D353–D361. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Xie C, Mao X, Huang J, Ding Y, Wu J, Dong
S, Kong L, Gao G, Li CY and Wei L: KOBAS 2.0: A web server for
annotation and identification of enriched pathways and diseases.
Nucleic Acids Res. 39:W316–W322. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Plieskatt JL, Rinaldi G, Feng Y, Levine
PH, Easley S, Martinez E, Hashmi S, Sadeghi N, Brindley PJ, Bethony
JM and Mulvenna JP: Methods and matrices: Approaches to identifying
miRNAs for nasopharyngeal carcinoma. J Transl Med. 12:32014.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lee KT, Tan JK, Lam AK and Gan SY:
MicroRNAs serving as potential biomarkers and therapeutic targets
in nasopharyngeal carcinoma: A critical review. Crit Rev Oncol
Hematol. 103:1–9. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Liang C, Zhang X, Wang HM, Liu XM, Zhang
XJ, Zheng B, Qian GR and Ma ZL: MicroRNA-18a-5p functions as an
oncogene by directly targeting IRF2 in lung cancer. Cell Death Dis.
8:e27642017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Xu X, Zhu S, Tao Z and Ye S: High
circulating miR-18a, miR-20a, and miR-92a expression correlates
with poor prognosis in patients with non-small cell lung cancer.
Cancer Med. 7:21–31. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Liang Q, Zhang G, Wang J and Sheng S:
Diagnostic value of MicroRNA-18a for gastric cancer: A
meta-analysis. Clin Lab. 64:177–184. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Liu P, Qi X, Bian C, Yang F, Lin X, Zhou
S, Xie C, Zhao X and Yi T: MicroRNA-18a inhibits ovarian cancer
growth via directly targeting TRIAP1 and IPMK. Oncol Lett.
13:4039–4046. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Lu M, Huang Y, Sun W, Li P and Li L:
miR-135b-5p promotes gastric cancer progression by targeting CMTM3.
Int J Oncol. 52:589–598. 2018.PubMed/NCBI
|
|
22
|
Zhang Z, Che X, Yang N, Bai Z, Wu Y, Zhao
L and Pei H: miR-135b-5p promotes migration, invasion and EMT of
pancreatic cancer cells by targeting NR3C2. Biomed Pharmacother.
96:1341–1348. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Palkina N, Komina A, Aksenenko M, Moshev
A, Savchenko A and Ruksha T: miR-204-5p and miR-3065-5p exert
antitumor effects on melanoma cells. Oncol Lett. 15:8269–8280.
2018.PubMed/NCBI
|
|
24
|
Shuai F, Wang B and Dong S: microRNA-204
inhibits the growth and motility of colorectal cancer cells by
downregulation of CXCL8. Oncol Res. 15:8269–8280. 2018.
|
|
25
|
Qu F, Ye J, Pan X, Wang J, Gan S, Chu C,
Chu J, Zhang X, Liu M, He H and Cui X: MicroRNA-497-5p
down-regulation increases PD-L1 expression in clear cell renal cell
carcinoma. J Drug Target. 27:1–15. 2018.PubMed/NCBI
|
|
26
|
Cheng H, Dong H, Feng J, Tian H, Zhang H
and Xu L: miR-497 inhibited proliferation, migration and invasion
of thyroid papillary carcinoma cells by negatively regulating YAP1
expression. Onco Targets Ther. 11:4711–4721. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Feng Y, Cao C, Hu Q and Chen X: Prognostic
value and staging classification of lymph nodal necrosis in
nasopharyngeal carcinoma after intensity-modulated radiotherapy.
Cancer Res Treat. 2018. View Article : Google Scholar
|
